Yarrow Bioscience YARW
NASDAQ YARW
$22.52 -1.67 (-6.90%)
At close: Sep 30, 2026 · 4:00 PM EDT

Yarrow Bioscience (YARW) EBIT Margin (2017 - 2026)

Updated

Yarrow Bioscience (YARW) recorded EBIT Margin of -3102.00% in Q2 2026, up 4440.00 percentage points from -7542.00% a year earlier and up 714.00 percentage points from the prior quarter.

Analysis

Yarrow Bioscience (YARW) EBIT Margin (2017 - 2026) Analysis & Trends

On a TTM basis, Yarrow Bioscience's EBIT Margin came in at -4712.55% as of Jun 30, 2026, up 3689.82 percentage points year-over-year; for FY2025, it was -4958.17%, up 3751.81 percentage points from FY2024.

  • Annual EBIT Margin has a five-year change of -3755.17 percentage points (FY2020 to FY2025).
  • Across earlier years, EBIT Margin came in at -8709.98% in FY2024 (-1809.51 pp), -6900.47% in FY2023 (-41.47 pp), -6859.00% in FY2022 (-2679.52 pp) and -4179.48% in FY2021 (-2976.48 pp).
  • The Q2 2026 figure is the highest quarterly EBIT Margin since Q4 2020.
  • On a year-over-year basis, EBIT Margin rose in three of the last six quarters, with an average year-over-year change of -983.92 percentage points.
  • Peak year-over-year performance for EBIT Margin in the last five years was a gain of 18541.56 percentage points in Q4 2023, against a drop of 24290.74 percentage points in Q4 2022 at the low end.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 28.21%
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 37.86%
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -3.52%
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 32.97%
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 20.57%
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 34.95%
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -133.21%
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 28.37%
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 37.40%
10 Yarrow Bioscience 19.32 Mn -97.19 Mn - -3,102.00%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -3,102.00%
Mar 31, 2026 -3,816.00%
Jun 30, 2025 -7,542.00%
Mar 31, 2025 -4,552.97%
Dec 31, 2024 -15,202.38%
Sep 30, 2024 -10,819.01%
Jun 30, 2024 -5,198.00%
Mar 31, 2024 -7,380.00%
Dec 31, 2023 -8,989.47%
Sep 30, 2023 -5,468.42%
Jun 30, 2023 -7,642.96%
Mar 31, 2023 -5,875.00%
Dec 31, 2022 -27,531.03%
Sep 30, 2022 -5,588.62%
Jun 30, 2022 -6,576.98%
Mar 31, 2022 -4,882.58%
Dec 31, 2021 -3,240.29%
Sep 30, 2021 -8,095.49%
Jun 30, 2021 -3,234.58%
Mar 31, 2021 -4,242.17%
API Access

Yarrow Bioscience EBIT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebit-margin&ticker=YARW&period=max&api_key=YOUR_API_KEY